Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer
Clinical trial NCT07695259 · RECRUITING
Trial details
- NCT number
- NCT07695259
- Sponsor
- Wen-Ming Cao
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-25
- Primary completion
- 2027-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.